Michele P. Calos, PhD


Michele Calos is currently a professor in the Department of Genetics at Stanford University School of Medicine, where she has focused on creating and utilizing innovative genetic engineering and gene delivery systems. Dr. Calos pursued undergraduate studies in Zoology at Oxford University, followed by a PhD in Biochemistry and Molecular Biology at Harvard University, working with Nobel laureate Dr. Walter Gilbert. Dr. Calos did postdoctoral research at the Universite de Geneve in Geneva, Switzerland, then moved to Stanford, where she became involved in gene therapy research.

Dr. Calos served on the Cellular, Tissue, and Gene Therapies Advisory Committee of the U.S. Food and Drug Administration from 2004-2008 and has been active in the American Society of Gene and Cell Therapy, with continuous committee assignments from 2003 to the present, including serving on the Board of Directors from 2007-2010, chairing the Musculo-Skeletal Gene and Cell Therapy Committee in 2016 and 2017, and serving as President-Elect in 2017.

Board & Officers

The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the Society.

22nd Annual Meeting
April 29 – May 2 | Washington D.C.